美康生物
(300439)
| 流通市值：28.91亿 | | | 总市值：37.96亿 |
| 流通股本：2.92亿 | | | 总股本：3.84亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 1,274,484,002.62 | 828,022,677.7 | 376,022,696.88 | 1,539,159,714.69 |
| 营业总成本 | 1,192,015,917.75 | 787,869,481.45 | 351,135,278.16 | 1,516,898,858.66 |
| 其他经营收益 | | | | |
| 营业利润 | 114,812,388.21 | 67,742,819.04 | 37,610,621.62 | 33,265,221.82 |
| 利润总额 | 109,060,116.7 | 66,438,388.21 | 36,976,398.24 | 46,092,646.26 |
| 净利润 | 99,049,367.57 | 61,555,662.61 | 33,187,998.12 | 61,361,976.78 |
| 每股收益 | | | | |
| 其他综合收益 | 1,621,964.1 | 1,251,247.48 | 737,416.79 | -628,731.08 |
| 综合收益总额 | 100,671,331.67 | 62,806,910.09 | 33,925,414.91 | 60,733,245.7 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 2,018,898,442.22 | 1,982,809,656.51 | 1,846,407,238.12 | 1,892,669,565.76 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,703,795,534.36 | 1,726,434,360.25 | 1,747,660,205.42 | 1,761,028,620.2 |
| 资产总计 | 3,722,693,976.58 | 3,709,244,016.76 | 3,594,067,443.54 | 3,653,698,185.96 |
| 流动负债: | | | | |
| 流动负债合计 | 618,329,306.3 | 640,483,180.56 | 534,005,769.7 | 623,985,598.16 |
| 非流动负债: | | | | |
| 非流动负债合计 | 68,502,271.23 | 71,402,847.62 | 78,902,660.27 | 82,078,989.14 |
| 负债合计 | 686,831,577.53 | 711,886,028.18 | 612,908,429.97 | 706,064,587.3 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 3,040,169,576.21 | 3,003,341,384.51 | 2,987,596,254.16 | 2,954,214,677.08 |
| 股东权益合计 | 3,035,862,399.05 | 2,997,357,988.58 | 2,981,159,013.57 | 2,947,633,598.66 |
| 负债和股东权益合计 | 3,722,693,976.58 | 3,709,244,016.76 | 3,594,067,443.54 | 3,653,698,185.96 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 1,343,823,635.67 | 917,110,209.52 | 401,149,719.09 | 1,567,591,925.06 |
| 经营活动现金流出小计 | 1,293,465,499.37 | 854,529,252.97 | 458,973,970.43 | 1,300,977,014.11 |
| 经营活动产生的现金流量净额 | 50,358,136.3 | 62,580,956.55 | -57,824,251.34 | 266,614,910.95 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 1,096,585,420.73 | 549,925,730.13 | 206,169,213.63 | 1,000,054,373.16 |
| 投资活动现金流出小计 | 1,432,046,008.48 | 722,384,160.35 | 213,945,535.89 | 1,258,407,877.19 |
| 投资活动产生的现金流量净额 | -335,460,587.75 | -172,458,430.22 | -7,776,322.26 | -258,353,504.03 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 60,000,000 | 60,000,000 | - | 37,538,668.06 |
| 筹资活动现金流出小计 | 43,914,863.18 | 37,067,135.08 | 20,085,510.47 | 114,251,446.15 |
| 筹资活动产生的现金流量净额 | 16,085,136.82 | 22,932,864.92 | -20,085,510.47 | -76,712,778.09 |
| 汇率变动对现金及现金等价物的影响 | -647,903.14 | -527,761.59 | -203,657.26 | -725,233.89 |
| 现金及现金等价物净增加额 | -269,665,217.77 | -87,472,370.34 | -85,889,741.33 | -69,176,605.06 |
| 期末现金及现金等价物余额 | 387,773,213.52 | 569,966,060.95 | 571,548,689.96 | 657,438,431.29 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -87,472,370.34 | - | -69,176,605.06 |